Linked Data API

Show Search Form

Search Results

100022
star this property registered interest false more like this
unstar this property date remove maximum value filtermore like thismore than 2014-10-15
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Patient Choice Schemes more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps he is taking to promote patient choice. more like this
star this property tabling member constituency Stroud more like this
star this property tabling member printed
Neil Carmichael more like this
star this property uin 905559 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-10-21more like thismore than 2014-10-21
star this property answer text <p>We are committed to patients having greater choice and control over their healthcare, as this can help drive up standards and improve patient care.</p><p> </p><p> </p><p> </p><p>We believe that patient empowerment is vital to the National Health Service in the 21st century. This Government is committed to continuing to develop digital platforms to enable this to happen, such as My NHS and the NHS e-Referral Service.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-21T16:00:56.1397924Zmore like thismore than 2014-10-21T16:00:56.1397924Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
unstar this property tabling member
4104
unstar this property label Biography information for Neil Carmichael more like this
65962
star this property registered interest false more like this
unstar this property date less than 2014-07-07more like thismore than 2014-07-07
star this property answering body
Department for Business, Innovation and Skills more like this
star this property answering dept id 26 more like this
star this property answering dept short name Business, Innovation and Skills more like this
star this property answering dept sort name Business, Innovation and Skills more like this
star this property hansard heading Life Sciences: Northern Ireland more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Business, Innovation and Skills, what work the Life Science Investment Organisation is doing to promote the life sciences sector in Northern Ireland. more like this
star this property tabling member constituency Bury South more like this
star this property tabling member printed
Mr Ivan Lewis more like this
star this property uin 204143 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-07-22more like thismore than 2014-07-22
star this property answer text <p>The Life Sciences Organisation (LSO) (previously the Life Sciences Investment Organisation, which now includes responsibility for UK trade promotion) works to promote the UK Life Sciences sector as a whole. LSO works closely with Invest Northern Ireland, along with the other devolved bodies and local enterprise partnerships across England, to understand the nation’s internationally competitive commercial offers in life sciences. We then actively market these strengths using our international network of investment advisors and suite of promotional materials. Where potential investors have specifically stated particular requirements, we will match these to the various regional offers and bring these out clearly in the tailored proposition materials produced for the investors.</p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-07-22T14:48:34.7611172Zmore like thismore than 2014-07-22T14:48:34.7611172Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
unstar this property tabling member
441
unstar this property label Biography information for Mr Ivan Lewis more like this
77653
star this property registered interest false more like this
unstar this property date less than 2014-07-14more like thismore than 2014-07-14
star this property answering body
Department for Business, Innovation and Skills more like this
star this property answering dept id 26 more like this
star this property answering dept short name Business, Innovation and Skills more like this
star this property answering dept sort name Business, Innovation and Skills more like this
star this property hansard heading Manufacturing Industries: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Business, Innovation and Skills, what steps his Department is taking to encourage international pharmaceutical companies to locate in the UK. more like this
star this property tabling member constituency Salisbury more like this
star this property tabling member printed
John Glen more like this
star this property uin 205633 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-08-28more like thismore than 2014-08-28
star this property answer text <p>In December 2011, the Government launched the Strategy for UK Life Sciences which includes measures to improve the commercial, research and regulatory environment, with the aim of making the UK the location of choice for investment. Government has also taken steps to strengthen protection for intellectual property in the UK.</p><p>In 2012 a specific organisation was set up to promote life sciences to international companies: the Life Sciences Investment Organisation (now reformed as the Life Sciences Organisation (LSO), with responsibility also for UK trade promotion). LSO collects and distils information on the UK’s internationally competitive commercial offers in life sciences; these are marketed to potential investors via the UK Trade and Investment global network of investment advisors, with tailored support provided to those investors that choose the UK.</p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-08-28T15:54:58.4454504Zmore like thismore than 2014-08-28T15:54:58.4454504Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
unstar this property tabling member
4051
unstar this property label Biography information for John Glen more like this
78736
star this property registered interest false more like this
unstar this property date less than 2014-07-17more like thismore than 2014-07-17
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Meningitis: Vaccination more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, whether the Bexsero vaccine is licensed for (a) individual application and (b) use in conjunction with other vaccines. more like this
star this property tabling member constituency The Cotswolds more like this
star this property tabling member printed
Geoffrey Clifton-Brown more like this
star this property uin 206537 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-09-02more like thismore than 2014-09-02
star this property answer text <p>Bexsero, a Meningococcal group B vaccine, was licenced for the active immunisation of individuals from two months of age and older against invasive meningococcal disease caused by <em>Neisseria meningitidis</em> group B. It can be administered individually or concomitantly with a number of other vaccine antigens, either as monovalent or as combination vaccines such as diphtheria, tetanus, acellular pertussis, <em>Haemophilus influenzae </em> type b, inactivated poliomyelitis, hepatitis B, heptavalent pneumococcal conjugate, measles, mumps, rubella, and varicella. When given concomitantly with other vaccines Bexsero must be administered at a separate injection site.</p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-09-02T13:40:37.255071Zmore like thismore than 2014-09-02T13:40:37.255071Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
unstar this property tabling member
249
unstar this property label Biography information for Sir Geoffrey Clifton-Brown more like this
78909
star this property registered interest false more like this
unstar this property date less than 2014-07-18more like thismore than 2014-07-18
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Parkinson's Disease more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, how many incidents of medication errors involving hospital patients with Parkinson's disease have been reported since the joint patient safety alert on steps to improve data reporting quality was issued by NHS England and the Medicines and Healthcare Products Regulatory Agency in March 2014. more like this
star this property tabling member constituency Newcastle upon Tyne North more like this
star this property tabling member printed
Catherine McKinnell more like this
star this property uin 206600 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-09-03more like thismore than 2014-09-03
star this property answer text <p>NHS England has advised that, between 20 March 2014 and 21 July 2014, 617 incidents in general, acute or community hospitals or mental health facilities involving Parkinson’s disease and medicines used to treat Parkinson’s disease were reported through the National Reporting and Learning System.</p><p>Improving services for people with Parkinson's disease and other neurological conditions is a key priority for NHS England. Its strategic clinical networks have a specific focus on patients with neurological problems, such as Parkinson’s disease. NHS trusts and care homes in England should have policies and procedures in place to ensure that people with Parkinson’s disease receive their medicines when they are required to take them to control their illness and symptoms.</p><p>NHS England has recently launched a medication ‘safety thermometer’ that enables health and care organisations to measure aspects of medication safety on a regular basis for improvement purposes. This will enable hospitals to track their progress in reducing the number of omitted doses of medicines, including of those used to treat Parkinson’s disease.</p><p> </p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property grouped question UIN 206629 more like this
star this property question first answered
less than 2014-09-03T09:44:33.9915993Zmore like thismore than 2014-09-03T09:44:33.9915993Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
unstar this property tabling member
4125
unstar this property label Biography information for Catherine McKinnell more like this
78911
star this property registered interest false more like this
unstar this property date less than 2014-07-18more like thismore than 2014-07-18
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Parkinson's Disease more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, with reference to the National Patient Safety Agency rapid response report on reducing harm from omitted and delayed medicines in hospital, what steps his Department has taken to ensure that hospitals in England and Wales are able to supply Parkinson's disease medications to patients in a timely way. more like this
star this property tabling member constituency Newcastle upon Tyne North more like this
star this property tabling member printed
Catherine McKinnell more like this
star this property uin 206629 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-09-03more like thismore than 2014-09-03
star this property answer text <p>NHS England has advised that, between 20 March 2014 and 21 July 2014, 617 incidents in general, acute or community hospitals or mental health facilities involving Parkinson’s disease and medicines used to treat Parkinson’s disease were reported through the National Reporting and Learning System.</p><p>Improving services for people with Parkinson's disease and other neurological conditions is a key priority for NHS England. Its strategic clinical networks have a specific focus on patients with neurological problems, such as Parkinson’s disease. NHS trusts and care homes in England should have policies and procedures in place to ensure that people with Parkinson’s disease receive their medicines when they are required to take them to control their illness and symptoms.</p><p>NHS England has recently launched a medication ‘safety thermometer’ that enables health and care organisations to measure aspects of medication safety on a regular basis for improvement purposes. This will enable hospitals to track their progress in reducing the number of omitted doses of medicines, including of those used to treat Parkinson’s disease.</p><p> </p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property grouped question UIN 206600 more like this
star this property question first answered
less than 2014-09-03T09:44:34.1195901Zmore like thismore than 2014-09-03T09:44:34.1195901Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
unstar this property tabling member
4125
unstar this property label Biography information for Catherine McKinnell more like this
79067
star this property registered interest false more like this
unstar this property date less than 2014-07-21more like thismore than 2014-07-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what provision is available to allow NHS patients to access specialised medication and drugs only available in the US. more like this
star this property tabling member constituency Preston more like this
star this property tabling member printed
Mark Hendrick more like this
star this property uin 206731 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-09-04more like thismore than 2014-09-04
star this property answer text <p> </p><p>The Human Medicines Regulations 2012 as amended contain provisions for the import of unlicensed medicinal products to meet the special clinical needs of particular patients. The importer (who must hold a licence for that purpose) must notify the Medicines and Healthcare products Regulatory Agency (MHRA) that such importation is taking place. The MHRA may object to the importation if there is a known safety or quality issue with the product, or if an equivalent United Kingdom-licensed product is available.</p><p> </p><p><strong> </strong></p><p> </p><p>Such products are used on the direct personal responsibility of the prescriber, who would retain clinical responsibility for the patient while prescribing the product in question.</p><p> </p><p> </p><p> </p><p>In primary care, prescribers are allowed to prescribe any product, including any unlicensed product, which they consider to be a medicine necessary for the treatment of their patients under the National Health Service, as long as that product is not included in Schedules 1 or 2 to the NHS (General Medical Services Contract) Regulations 2004 and that the prescriber is prepared to justify any challenges to their prescribing by the relevant commissioning organisation.</p><p> </p><p><strong> </strong></p><p>When a patient is being treated by a hospital the consultant can arrange for the supply of any product, even one not normally available on NHS prescription, provided the relevant commissioning organisation or NHS trust agrees to supply it at NHS expense.</p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-09-04T13:25:54.5785247Zmore like thismore than 2014-09-04T13:25:54.5785247Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
unstar this property tabling member
473
unstar this property label Biography information for Sir Mark Hendrick more like this
79074
star this property registered interest false more like this
unstar this property date less than 2014-07-21more like thismore than 2014-07-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Congenital Myasthenic Syndrome more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what discussions he has had with the British Medical Association on the prescribing of salbutamol to treat congenital myasthenia. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 206798 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-09-04more like thismore than 2014-09-04
star this property answer text <p>Ministers have had no such discussions.</p><p>Salbutamol is not licenced for the treatment of congenital myasthenia. Doctors can prescribe a medicine outside the terms of its licence if this best meets the clinical need of an individual patient and on condition that they retain full clinical responsibility for that patient.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-09-04T13:56:17.9375957Zmore like thismore than 2014-09-04T13:56:17.9375957Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
unstar this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
79378
star this property registered interest false more like this
unstar this property date less than 2014-07-22more like thismore than 2014-07-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Radiotherapy more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, pursuant to the Answer of 21 July 2014, Official Report, column 1007W, on radiotherapy, when data relating to individual funding requests per indication for radiotherapy treatment made to NHS England and the number of such requests refused will be available from NHS England. more like this
star this property tabling member constituency Wells more like this
star this property tabling member printed
Tessa Munt more like this
star this property uin 206964 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-09-04more like thismore than 2014-09-04
star this property answer text <p> </p><p>NHS England has advised us that it is aiming to complete its work on improving data collection for individual funding requests later this year. This will include information on requests received for radiotherapy treatments.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-09-04T13:29:56.5469293Zmore like thismore than 2014-09-04T13:29:56.5469293Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
unstar this property tabling member
4089
unstar this property label Biography information for Tessa Munt more like this
79384
star this property registered interest false more like this
unstar this property date less than 2014-07-22more like thismore than 2014-07-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Drugs: Licensing more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what assessment he has made of the prevalence and efficacy of the procurement and use of off-patent drugs in the NHS. more like this
star this property tabling member constituency South Down more like this
star this property tabling member printed
Ms Margaret Ritchie more like this
star this property uin 206976 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-09-01more like thismore than 2014-09-01
star this property answer text <p> </p><p>We have made no such assessment.</p><p> </p><p> </p><p> </p><p>There are mechanisms in place to ensure that the reimbursement prices paid by the National Health Service to dispensing contractors for generic (off-patent) medicines dispensed in primary care provide value for money for the NHS in the majority of instances.</p><p> </p><p> </p><p> </p><p>For example, Part VIII of the Drug Tariff lists the most commonly prescribed products with a reimbursement price that dispensing contractors will be paid. Setting a reimbursement price encourages contractors to seek lower prices and procure in a manner that is cost-effective for the NHS.</p><p> </p><p> </p><p> </p><p>In 2013, 83.9% of NHS prescriptions in primary care were prescribed generically.</p><p> </p><p> </p><p>Generic products in secondary care are tendered by the Department’s Commercial Medicines Unit in collaboration with the NHS through a national programme that ensures value for money by offering the NHS’ requirement to the market on a consolidated basis, whilst ensuring quality standards are maintained.</p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-09-01T16:04:27.434869Zmore like thismore than 2014-09-01T16:04:27.434869Z
star this property answering member
4020
star this property label Biography information for George Freeman remove filter
unstar this property tabling member
4130
unstar this property label Biography information for Ms Margaret Ritchie more like this